Maravai LifeSciences (MRVI)
(Delayed Data from NSDQ)
$7.39 USD
+0.09 (1.16%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $7.36 -0.03 (-0.34%) 7:58 PM ET
5-Strong Sell of 5 5
C Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/8/24 |
---|---|
Current Quarter | -0.03 |
EPS Last Quarter | 0.01 |
Last EPS Surprise | 200.00% |
ABR | 1.63 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.01 |
Next Year | 0.05 |
EPS (TTM) | 0.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 60.84M | 68.04M | 273.56M | 301.82M |
# of Estimates | 5 | 5 | 5 | 6 |
High Estimate | 62.20M | 68.80M | 275.10M | 330.00M |
Low Estimate | 59.70M | 67.30M | 268.91M | 290.78M |
Year ago Sales | 79.03M | 68.91M | 288.95M | 273.56M |
Year over Year Growth Est. | -23.02% | -1.26% | -5.33% | 10.33% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.03 | -0.01 | -0.01 | 0.05 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | -0.02 | 0.00 | 0.02 | 0.06 |
High Estimate | -0.02 | 0.00 | 0.03 | 0.09 |
Low Estimate | -0.03 | -0.01 | -0.03 | 0.02 |
Year ago EPS | 0.03 | 0.00 | 0.03 | -0.01 |
Year over Year Growth Est. | -200.00% | NA | -133.33% | 533.34% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 2 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.03 | -0.01 | -0.01 | 0.05 |
7 Days Ago | -0.03 | -0.01 | -0.01 | 0.05 |
30 Days Ago | -0.03 | -0.01 | -0.01 | 0.05 |
60 Days Ago | -0.01 | -0.01 | 0.03 | 0.10 |
90 Days Ago | 0.00 | 0.01 | 0.06 | 0.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.03 | -0.01 | -0.01 | 0.05 |
Zacks Consensus Estimate | -0.03 | -0.01 | -0.01 | 0.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.01 | -0.01 | 0.00 | 0.03 | NA |
Estimate | -0.01 | 0.00 | 0.01 | 0.04 | NA |
Difference | 0.02 | -0.01 | -0.01 | -0.01 | 0.00 |
Surprise | 200.00% | NA | -100.00% | -25.00% | 25.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more